CIBC World Market’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$693K Buy
6,336
+948
+18% +$98.1K ﹤0.01% 1113
2026
Q1
$560K Buy
5,388
+523
+11% +$55.7K ﹤0.01% 1089
2025
Q4
$502K Buy
4,865
+583
+14% +$56.7K ﹤0.01% 1124
2025
Q3
$387K Buy
4,282
+207
+5% +$18.1K ﹤0.01% 1168
2025
Q2
$358K Sell
4,075
-373
-8% -$32.3K ﹤0.01% 1131
2025
Q1
$405K Buy
4,448
+350
+9% +$31.5K ﹤0.01% 1088
2024
Q4
$354K Sell
4,098
-19,007
-82% -$1.72M ﹤0.01% 1131
2024
Q3
$2.2M Buy
23,105
+1,585
+7% +$151K ﹤0.01% 651
2024
Q2
$1.97M Buy
21,520
+18,704
+664% +$1.67M ﹤0.01% 648
2024
Q1
$255K Buy
2,816
+351
+14% +$30.7K ﹤0.01% 1157
2023
Q4
$201K Buy
+2,465
New +$193K ﹤0.01% 1175
2023
Q1
Sell
-2,640
Closed -$205K 1322
2022
Q4
$205K Buy
+2,640
New +$195K ﹤0.01% 1164
2022
Q3
Sell
-3,212
Closed -$247K 1302
2022
Q2
$247K Buy
+3,212
New +$251K ﹤0.01% 1082

Other funds holding PPH

CIBC World Market's PPH Position: Q2 2026 in Review

CIBC World Market increased its VanEck Pharmaceutical ETF (PPH) stake by 18% in Q2 2026, buying an estimated $98.1K and bringing the position to 6,336 shares worth $693K. The position accounts for ﹤0.01% of the portfolio, ranked #1113.

CIBC World Market first reported a position in PPH in Q2 2022 and has held it in 13 quarters since. The position peaked at $2.2M in Q3 2024. 117 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • CIBC World Market held 6,336 shares of VanEck Pharmaceutical ETF worth $693K as of Q2 2026.
  • CIBC World Market bought 948 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $98.1K.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #1113 holding.
  • CIBC World Market first reported a position in VanEck Pharmaceutical ETF in Q2 2022 and has held it in 13 quarters since.
  • CIBC World Market's VanEck Pharmaceutical ETF position peaked at $2.2M in Q3 2024.
  • 117 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.